Contraceptive discontinuation is a key indicator of the quality of care provided within a family planning programme. Comparison of headline rates of contraceptive discontinuation can be problematic due to differential prevalences of ‘cured fractions’- women who have a zero probability of discontinuation. These women are heavily concentrated among long term contraceptive method dispensed by public sector providers, and comparison of discontinuation rates without accounting for cured fractions can be misleading. This analysis therefore uses cure models to evaluate contraceptive discontinuation using DHS calendar data and a 7 countries in sub-Saharan Africa. Results indicate that a substantial part of slower rates of discontinuation among long term modern method users can be explained by cured fractions. Conditioning on this, discontinuation rates are higher among users of these methods, potentially indicating a greater rate of side-effect related discontinuation and implications for care provided by public sector providers.
The fundamental technical piece of understanding we need here is the idea of a 'cure model,' aka a split or two population model. The basic idea is that in standard event history models, we are looking at the rate that a particular event occurs over time. The problem being, that under our two population framework, some of the people we observe are not truly at risk of the event occurring. This is common under circumstances where we are looking at the recurrence of a disease, but we 'cure' a certain proportion of patients (hence the 'cure' model). Under the circumstances we are looking at, contraceptive discontinuation, we can think of women as being 'cured' from contraceptive discontinuation under circumstances where they are
- Are practising stopping behaviour (so have no risk of contraceptive abandonment)
- Are using a reliable contraceptive diligently (so have no risk of contraceptive failure)
- Are happy with their current method (so have no risk of method switching)
This leads us to an analysis where using a definition of contraceptive discontinuation consistent with the DHS that is vulnerable to bias, due to the presence of women fulfilling these criteria. The specific bias we are talking about is illustrated below: we are including women in the risk set who have no risk of experiencing the event, are will continue within our population until the end of time
Why this matters is because the distribution of the cured women is likely to be correlated with certain variables we might be interested in- for instance, there may be variation across country or between different providers. Where we are using continuation rates as an indicator of quality for family planning programmes (Jain 1989, Bruce 1990) this is problematic: some of the 'good' performance is merely reflecting variation in terms of the women served and our comparison is subject to a selection bias.
This is probably the most obvious point of attack for this analysis- particularly for contraceptive switching: it's easy circumstances where a woman changes to a more suitable method. I would, however, whether this really detracts from the idea that there is some degree of programmatic failure involved in that decision. Why was the preferred method not available in the first place? If women change method a lot to a string of 'preferred' methods, is contraceptive counselling really adequate? Besides, even if the change really is desirable, there are still positive risks in the contraceptive change relevant to programme evaluation, such as an elevated risk of accidental pregnancy, regardless of whether the switch is desirable in terms of user satisfaction.
The results of the analysis using the DHS definition of contraceptive discontinuation is presented below. We are making cross-national comparisons here, based on a country selection described in other analyses and using the contraceptive calendar, one of the more reliable means of collecting contraceptive use. Results are presented below, comparing the hazard of contraceptive discontinuation for long term methods (IUD, Male sterilisation, Female sterilisation, Implant) to all other methods for both usual event history and cure models.
Looking at the column for the hazard model, we can see coefficient which are generally below 1 for most countries. This indicates that in most setting, users of of long term contraceptives are less likely to discontinue contraceptive use that women using a short term method (this is a fairly intuitive result). In terms of a naive policy recommendation, this would tend to point us toward encouraging the use of long term methods: where lower rates of contraceptive discontinuation are desirable from a quality perspective this would tend to be a means of lower the rate at which women stop using contraceptive.
However, the column on the right, which accounts for our cured fraction has a slightly more mixed result. Of the 5 countries which had significant coefficients below 1, only 2 remain (Burkina Faso and Malawi). In contrast, we now have 4 coefficients which are above 1, indicating that, accounting for our selection effect, women who use a long term method are more likely to stop using that method than short term method users. Our policy recommendation here is radically different: our call would be to improve the quality of contraceptive counselling for long term method users to reduce their inflating discontinuation rates. This is particularly relevant where there is a greater propensity for women to accept a long term methods, such as in the public sector (Campbell et al 2015). Moreover, it reinforces the conclusions I have made in previous posts
selection effects exist within family planning and that failing to account for these can lead policy makers to overplay their hand when advocating certain solutions. If we want to use genuine evidence based policy we need to think about the nature of behaviours we are generating evidence about: simple regression may not be adequate.